Revisiting ABCB1 polymorphism: a missing piece in Alzheimer’s risk and treatment? by Théodore Decaix, Elodie Bouaziz-Amar, Claire Paquet, Matthieu Lilamand

Get full text

Dual risk of anticholinergic burden and CSF alzheimer’s biomarkers in older patients: a mortality follow-up study from daily medical practice by Théodore Decaix, Julien Dumurgier, Emmanuel Cognat, Karl Götze, François Mouton-Liger, Jacques Hugon, Elodie Bouaziz-Amar, Matthieu Lilamand, Claire Paquet

Get full text

Dissection of blood–brain barrier dysfunction through CSF PDGFRβ and amyloid, tau, neuroinflammation, and synaptic CSF biomarkers in neurodegenerative disordersResearch in context... by Agathe Vrillon, Nicholas J. Ashton, Elodie Bouaziz-Amar, François Mouton-Liger, Emmanuel Cognat, Julien Dumurgier, Matthieu Lilamand, Thomas K. Karikari, Vincent Prevot, Henrik Zetterberg, Kaj Blennow, Claire Paquet

Get full text

Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study. by Hana Saddiki, Aurore Fayosse, Emmanuel Cognat, Séverine Sabia, Sebastiaan Engelborghs, David Wallon, Panagiotis Alexopoulos, Kaj Blennow, Henrik Zetterberg, Lucilla Parnetti, Inga Zerr, Peter Hermann, Audrey Gabelle, Mercè Boada, Adelina Orellana, Itziar de Rojas, Matthieu Lilamand, Maria Bjerke, Christine Van Broeckhoven, Lucia Farotti, Nicola Salvadori, Janine Diehl-Schmid, Timo Grimmer, Claire Hourregue, Aline Dugravot, Gaël Nicolas, Jean-Louis Laplanche, Sylvain Lehmann, Elodie Bouaziz-Amar, Alzheimer’s Disease Neuroimaging Initiative, Jacques Hugon, Christophe Tzourio, Archana Singh-Manoux, Claire Paquet, Julien Dumurgier

Get full text